Phytochemicals, micrornas, and cancer: Implications for cancer prevention and therapy

Mitochondria as Targets for Phytochemicals in Cancer Prevention and Therapy

Volumn , Issue , 2013, Pages 187-206

  Srivastava, Sanjeev K ^a   Arora, Sumit ^a   Singh, Seema ^a   Singh, Ajay P ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Alkaloids; Cancer prevention and therapy; Carotenoids; MicroRNAs; Organosulfurs; Phenolics; Phytochemicals

Indexed keywords

EID: 84908154368     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-9326-6_9     Document Type: Chapter

References (145)

1. Agelaki S, Kontopodis E, Kotsakis A, Chandrinos V, Bompolaki I, Zafeiriou Z et al (2013) A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancer. Cancer Chemother Pharmacol
2. Asher GN, Spelman K (2013) Clinical utility of curcumin extract. Altern Ther Health Med 19:20–22
3. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR et al (2007) Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 224:274–283
4. Bar-Sela G, Epelbaum R, Schaffer M (2010) Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr Med Chem 17:190–197
5. Bashandy T, Taconnat L, Renou JP, Meyer Y, Reichheld JP (2009) Accumulation of flavonoids in an ntra ntrb mutant leads to tolerance to UV-C. Mol Plant 2:249–258
6. Bhardwaj A, Singh S, Singh AP (2010) MicroRNA-based cancer therapeutics: big hope from small RNAs. Mol Cell Pharmacol 2:213–219
7. Bible KC, Peethambaram PP, Oberg AL, Maples W, Groteluschen DL, Boente M et al (2012) A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261. Gynecol Oncol 127:55–62
8. Bishayee A, Politis T, Darvesh AS (2010) Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma. Cancer Treat Rev 36:43–53
9. Bjorkholm M (1990) Etoposide and teniposide in the treatment of acute leukemia. Med Oncol Tumor Pharmacother 7:3–10
10. Block G (1992) Vitamin C status and cancer. Epidemiologic evidence of reduced risk. Ann N Y Acad Sci 669:280–290 discussion 290–292:280–290
11. Bohm F, Edge R, Truscott TG (2012) Interactions of dietary carotenoids with singlet oxygen (1O2) and free radicals: potential effects for human health. Acta Biochim Pol 59:27–30
12. Bruce JN, Fine RL, Canoll P, Yun J, Kennedy BC, Rosenfeld SS et al (2011) Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan. Neurosurgery 69:1272–1279
13. Burgeiro A, Bento AC, Gajate C, Oliveira PJ, Mollinedo. F (2013) Rapid human melanoma cell death induced by sanguinarine through oxidative stress. Eur J Pharmacol 705:109–118
14. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857–866
15. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99:15524–15529
16. Caperle M, Maiani G, Azzini E, Conti EM, Raguzzini A, Ramazzotti V et al (1996) Dietary profiles and anti-oxidants in a rural population of central Italy with a low frequency of cancer. Eur J Cancer Prev 5:197–206
17. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029–6033
18. Chan KC, Mong MC, Yin MC (2009) Antioxidative and anti-inflammatory neuroprotective effects of astaxanthin and canthaxanthin in nerve growth factor differentiated PC12 cells. J Food Sci 74:H225–H231
19. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH et al (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26:745–752
20. Chen JJ, Ye ZQ, Koo MW (2004) Growth inhibition and cell cycle arrest effects of epigallocatechin gallate in the NBT-II bladder tumour cell line. BJU Int 93:1082–1086
21. Chen Y, Zaman MS, Deng G, Majid S, Saini S, Liu J et al (2011) MicroRNAs 221/222 and genistein–mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev Res (Phila) 4:76–86
22. Chu YF, Sun J, Wu X, Liu RH (2002) Antioxidant and antiproliferative activities of common vegetables. J Agric Food Chem 50:6910–6916
23. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al (2005) miR-15 and miR–16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 102:13944–13949
24. Cohen LA, Zhao Z, Pittman B, Khachik F (1999) Effect of dietary lycopene on N-methylnitrosourea–induced mammary tumorigenesis. Nutr Cancer 34:153–159
25. Corradini E, Foglia P, Giansanti P, Gubbiotti R, Samperi R, Lagana A (2011) Flavonoids: chemical properties and analytical methodologies of identification and quantitation in foods and plants. Nat Prod Res 25:469–495
26. Cragg GM, Newman DJ (2005) Plants as a source of anti-cancer agents. J Ethnopharmacol 100:72–79
27. Crawford M, Brawner E, Batte K, Yu L, Hunter MG, Otterson GA et al (2008) MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun 373:607–612
28. Creemers GJ, Bolis G, Gore M, Scarfone G, Lacave AJ, Guastalla JP et al (1996) Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study. J Clin Oncol 14:3056–3061
29. da Rocha AB, Lopes RM, Schwartsmann G (2001) Natural products in anticancer therapy. Curr Opin Pharmacol 1:364–369
30. Dai J, Mumper RJ (2010) Plant phenolics: extraction, analysis and their antioxidant and anticancer properties. Molecules 15:7313–7352
31. Davenport DM, Wargovich MJ (2005) Modulation of cytochrome P450 enzymes by organosulfur compounds from garlic. Food Chem Toxicol 43:1753–1762
32. Davies AM, Lara PN Jr., Mack PC, Gandara DR (2003) Docetaxel in non-small cell lung cancer: a review. Expert Opin Pharmacother 4:553–565
33. Del Follo-Martinez A, Banerjee N, Li X, Safe S, Mertens-Talcott S (2013) Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a. Nutr Cancer 65:494–504
34. Deorukhkar A, Krishnan S, Sethi G, Aggarwal BB (2007) Back to basics: how natural products can provide the basis for new therapeutics. Expert Opin Investig Drugs 16:1753–1773
35. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E et al (2006) Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38:1060–1065
36. Dickson MA, Shah MA, Rathkopf D, Tse A, Carvajal RD, Wu N et al (2010) A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol. Cancer Chemother Pharmacol 66:1113–1121
37. Diogo CV, Machado NG, Barbosa IA, Serafim TL, Burgeiro A, Oliveira PJ (2011) Berberine as a promising safe anti-cancer agent—is there a role for mitochondria? Curr Drug Targets 12:850–859
38. Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, Mongera S, Postma C, Meijerink WJ et al (2009) MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 101:707–714
39. Fotsis T, Pepper MS, Montesano R, Aktas E, Breit S, Schweigerer L et al (1998) Phytoestrogens and inhibition of angiogenesis. Baillieres Clin Endocrinol Metab 12:649–666
40. Fresco P, Borges F, Diniz C, Marques MP (2006) New insights on the anticancer properties of dietary polyphenols. Med Res Rev 26:747–766
41. Fuchs C, Mitchell EP, Hoff PM (2006) Irinotecan in the treatment of colorectal cancer. Cancer Treat Rev 32:491–503
42. Fukushima S, Takada N, Hori T, Wanibuchi H (1997) Cancer prevention by organosulfur compounds from garlic and onion. J Cell Biochem Suppl 27:100–105
43. Fulda S (2009) Betulinic acid: a natural product with anticancer activity. Mol Nutr Food Res 53:140–146
44. Garofalo M, Quintavalle C, Di LG, Zanca C, Romano G, Taccioli C et al (2008) MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene 19(27):3845–3855
45. Greither T, Grochola LF, Udelnow A, Lautenschlager C, Wurl P, Taubert H (2010) Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 126:73–80
46. Ha TY (2011) MicroRNAs in human diseases: from cancer to cardiovascular disease. Immune Netw 11:135–154
47. Hagiwara K, Kosaka N, Yoshioka Y, Takahashi RU, Takeshita F, Ochiya T (2012) Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity. Sci Rep 2:314. doi:10.1038/srep00314. Epub;%2012 Mar 15.:314
48. Harvey AL (2008) Natural products in drug discovery. Drug Discov Today 13:894–901
49. Hassan HT (2011) Prospective clinical role for anticancer garlic organosulfur compounds. Anticancer Agents Med Chem 11:247–248
50. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S et al (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65:9628–9632
51. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al (2005) A microRNA polycistron as a potential human oncogene. Nature 435:828–833
52. Huang M, Gao H, Chen Y, Zhu H, Cai Y, Zhang X et al (2007) Chimmitecan, a novel 9-substituted camptothecin, with improved anticancer pharmacologic profiles in vitro and in vivo. Clin Cancer Res 13:1298–1307
53. Huang Q, Gumireddy K, Schrier M, le SC, Nagel R, Nair S et al (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10:202–210
54. Hui C, Yujie F, Lijia Y, Long Y, Hongxia X, Yong Z et al (2012) MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosoureainduced breast carcinogenesis. Breast Cancer Res 14:R80
55. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065–7070
56. Jacob JK, Tiwari K, Correa-Betanzo J, Misran A, Chandrasekaran R, Paliyath G (2012) Biochemical basis for functional ingredient design from fruits. Annu Rev Food Sci Technol 3:79–104. doi:10.1146/annurev-food-022811-101127. Epub;%2012 Jan 3:79–104
57. Javeri A, Ghaffarpour M, Taha MF, Houshmand M (2013) Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis. Med Oncol 30:413–0413
58. Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L et al (2009) MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 4:e6816
59. Jiang S, Zhang HW, Lu MH, He XH, Li Y, Gu H et al (2010) MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 70:3119–3127
60. Jiang X, Huang H, Li Z, He C, Li Y, Chen P et al (2012) MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia. Proc Natl Acad Sci U S A %20;109:19397–19402
61. Jin Y (2011) 3,3’-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation. Mol Cell Biochem 358:345–354
62. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al (2005) RAS is regulated by the let-7 microRNA family. Cell 120:635–647
63. Kampa M, Alexaki VI, Notas G, Nifli AP, Nistikaki A, Hatzoglou A et al (2004) Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res 6:R63–R74
64. Khor TO, Keum YS, Lin W, Kim JH, Hu R, Shen G et al (2006) Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. Cancer Res 66:613–621
65. Knekt P, Jarvinen R, Seppanen R, Hellovaara M, Teppo L, Pukkala E et al (1997) Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 146:223–230
66. Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF et al (2008) Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther 7:2152–2159
67. Krishnakumar N, Manoharan S, Palaniappan PR, Venkatachalam P, Manohar MG (2009) Chemopreventive efficacy of piperine in 7,12-dimethyl benz [a] anthracene (DMBA)-induced hamster buccal pouch carcinogenesis: an FT-IR study. Food Chem Toxicol 47:2813–2820
68. Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11:597–610
69. Lawrie CH (2007) MicroRNA expression in lymphoma. Expert Opin Biol Ther 7:1363–1374
70. Lea MA (1996) Organosulfur compounds and cancer. Adv Exp Med Biol 401:147–154
71. Lee KW, Bode AM, Dong Z (2011) Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer 11:211–218
72. Li W, Xie L, He X, Li J, Tu K, Wei L et al (2008) Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int J Cancer 123:1616–1622
73. Li Y, Chinni SR, Senderowicz AM, Sarkar FH (2000) Induction of growth inhibition and apoptosis in prostate cancer cells by flavopiridol. Int J Oncol 17:755–759
74. Li Y, VandenBoom TG, Kong D, Wang Z, Ali S, Philip PA et al (2009) Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 69:6704–6712
75. Li Y, VandenBoom TG, Wang Z, Kong D, Ali S, Philip PA et al (2010) miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res 70:1486–1495
76. Liu RH (2004) Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 134:3479S–3485S
77. Lu JJ, Bao JL, Chen XP, Huang M, Wang YT (2012) Alkaloids isolated from natural herbs as the anticancer agents. Evid Based Complement Alternat Med 2012:485042. doi:10.1155/2012/485042. Epub;%2012 Sep 4:485042
78. Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682–688
79. Middleton E Jr, Kandaswami C, Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52:673–751
80. Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL et al (2008) MicroRNA–221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 283:29897–29903
81. Minich DM, Bland JS (2007) A review of the clinical efficacy and safety of cruciferous vegetable phytochemicals. Nutr Rev 65:259–267
82. Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG (1972) Phase II study of camptothecin (NSC–100880) in the treatment of advanced gastrointestinal cancer. Cancer Chemother Rep 56:95–101
83. Moriarty RM, Naithani R, Surve B (2007) Organosulfur compounds in cancer chemoprevention. Mini Rev Med Chem 7:827–838
84. Mudduluru G, George-William JN, Muppala S, Asangani IA, Kumarswamy R, Nelson LD et al (2011) Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci Rep 31:185–197
85. Mullauer FB, Kessler JH, Medema JP (2010) Betulinic acid, a natural compound with potent anticancer effects. Anticancer Drugs 21:215–227
86. Musa F, Blank S, Muggia F (2013) A pharmacokinetic evaluation of topotecan as a cervical cancer therapy. Expert Opin Drug Metab Toxicol 9:215–224
87. Musiyenko A, Bitko V, Barik S (2008) Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells. J Mol Med (Berl) 86:313–322
88. Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70:461–477
89. Nichenametla SN, Taruscio TG, Barney DL, Exon JH (2006) A review of the effects and mechanisms of polyphenolics in cancer. Crit Rev Food Sci Nutr 46:161–183
90. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74:418–425
91. Papagiannakopoulos T, Shapiro A, Kosik KS (2008) MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 68:8164–8172
92. Piccart M (2003) The role of taxanes in the adjuvant treatment of early stage breast cancer. Breast Cancer Res Treat 79 Suppl 1:S25–34.:S25–S34
93. Pillai RS (2005) MicroRNA function: multiple mechanisms for a tiny RNA? RNA 11:1753–1761
94. Reddy L, Odhav B, Bhoola KD (2003) Natural products for cancer prevention: a global perspective. Pharmacol Ther 99:1–13
95. Reuter S, Gupta SC, Park B, Goel A, Aggarwal BB (2011) Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr 6:93–108
96. Rhodes LV, Tilghman SL, Boue SM, Wang S, Khalili H, Muir SE et al (2012) Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer. Oncol Lett 3:163–171
97. Ross SA, Davis CD (2011) MicroRNA, nutrition, and cancer prevention. Adv Nutr 2:472–485
98. Russo M, Spagnuolo C, Tedesco I, Russo GL (2010) Phytochemicals in cancer prevention and therapy: truth or dare? Toxins (Basel) 2:517–551
99. Saini S, Arora S, Majid S, Shahryari V, Chen Y, Deng G et al (2011) Curcumin modulates microRNA–203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev Res (Phila) 4:1698–1709
100. Salerno E, Scaglione BJ, Coffman FD, Brown BD, Baccarini A, Fernandes H et al (2009) Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity. Mol Cancer Ther 8:2684–2692
101. Salvo VA, Boue SM, Fonseca JP, Elliott S, Corbitt C, Collins-Burow BM et al (2006) Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis. Clin Cancer Res 12:7159–7164
102. Sarkar FH, Adsule S, Padhye S, Kulkarni S, Li Y (2006) The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy. Mini Rev Med Chem 6:401–407
103. Sassen S, Miska EA, Caldas C (2008) MicroRNA: implications for cancer. Virchows Arch 452:1–10
104. Senderowicz AM (1999) Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials. Invest New Drugs 17:313–320
105. Shen JP, Yang H, Ni WM, Qian WB (2012) Cytotoxicity of homoharringtonine on leukemic stemlike cells in AML cell line KG-1. Zhejiang Da Xue Xue Bao Yi Xue Ban 41:485–490
106. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY (2007) miR-21-mediated tumor growth. Oncogene 26:2799–2803
107. Siddiqui IA, Asim M, Hafeez BB, Adhami VM, Tarapore RS, Mukhtar H (2011) Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J 25:1198–1207
108. Singh S (2007) From exotic spice to modern drug? Cell 130:765–768
109. Spagnuolo C, Russo M, Bilotto S, Tedesco I, Laratta B, Russo GL (2012) Dietary polyphenols in cancer prevention: the example of the flavonoid quercetin in leukemia. Ann N Y Acad Sci 1259:95–103. doi:10.1111/j.1749-6632.2012.06599.x
110. Sripada L, Tomar D, Singh R (2012) Mitochondria: one of the destinations of miRNAs. Mitochondrion 12:593–599
111. Srivastava S, Bhardwaj A, Leavesley S, Grizzle W, Singh S, Singh A (2013) MicroRNAs as potential clinical biomarkers: emerging approaches for their detection. Biotech Histochem
112. Srivastava SK, Bhardwaj A, Singh S, Arora S, Wang B, Grizzle WE et al (2011) MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis 32:1832–1839
113. Steinmetz KA, Potter JD (1996) Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 96:1027–1039
114. Sun J, Chu YF, Wu X, Liu RH (2002) Antioxidant and antiproliferative activities of common fruits. J Agric Food Chem 50:7449–7454
115. Sun XD, Liu XE, Huang DS (2013) Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway. Oncol Rep 29:2401–2407
116. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H et al (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64:3753–3756
117. Takeshita F, Patrawala L, Osaki M, Takahashi RU, Yamamoto Y, Kosaka N et al (2010) Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther 18:181–187
118. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD et al (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451:147–152
119. Tili E, Michaille JJ, Alder H, Volinia S, Delmas D, Latruffe N et al (2010) Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFbeta signaling pathway in SW480 cells. Biochem Pharmacol 80:2057–2065
120. Tsai CW, Yang JJ, Chen HW, Sheen LY, Lii CK (2005) Garlic organosulfur compounds upregulate the expression of the pi class of glutathione S-transferase in rat primary hepatocytes. J Nutr 135:2560–2565
121. Tsang WP, Kwok TT (2010) Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J Nutr Biochem 21:140–146
122. Ulukan H, Swaan PW (2002) Camptothecins: a review of their chemotherapeutic potential. Drugs 62:2039–2057
123. Vaishampayan U, Parchment RE, Jasti BR, Hussain M (1999) Taxanes: an overview of the pharmacokinetics and pharmacodynamics. Urology 54:22–29
124. Vuddanda PR, Chakraborty S, Singh S (2010) Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opin Investig Drugs 19:1297–1307
125. Wahle KW, Brown I, Rotondo D, Heys SD (2010) Plant phenolics in the prevention and treatment of cancer. Adv Exp Med Biol 698:36–51
126. Wang G, Mao W, Zheng S (2008) MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett 582:3663–3668
127. Wang H, Bian S, Yang CS (2011) Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1alpha. Carcinogenesis 32:1881–1889
128. Wang L, Cao H, Lu N, Liu L, Wang B, Hu T et al (2013) Berberine inhibits proliferation and down-regulates epidermal growth factor receptor through activation of Cbl in colon tumor cells. PLoS One 8:e56666
129. Weidhaas JB, Babar I, Nallur SM, Trang P, Roush S, Boehm M et al (2007) MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 67:11111–11116
130. Weng CJ, Yen GC (2012) Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer Metastasis Rev 31:323–351
131. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S et al (2008) miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 123:372–379
132. Yang H, Kong W, He L, Zhao JJ, O’Donnell JD, Wang J et al (2008) MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68:425–433
133. Yang K, Handorean AM, Iczkowski KA (2009) MicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro. Int J Clin Exp Pathol 2:361–369
134. Yang J, Cao Y, Sun J, Zhang Y (2010) Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells. Med Oncol 27:1114–1118
135. Yang J, Cai X, Lu W, Hu C, Xu X, Yu Q et al (2013) Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells. Cancer Lett 328:243–251
136. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C et al (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131:1109–1123
137. Yuan Y, Li W, Lin D, Mi YC, Wang Y, Wei H et al (2011) Outcome of acute promyelocytic leukemia with homoharringtonine (HHT) and ATRA. Zhonghua Xue Ye Xue Za Zhi 32:752–757
138. Zeng CW, Zhang XJ, Lin KY, Ye H, Feng SY, Zhang H et al (2012) Camptothecin induces apoptosis in cancer cells via microRNA-125b-mediated mitochondrial pathways. Mol Pharmacol 81:578–586
139. Zhang L, Coukos G (2006) MicroRNAs: a new insight into cancer genome. Cell Cycle 5:2216–2219
140. Zhang B, Pan X, Cobb GP, Anderson TA (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302:1–12
141. Zhang H, Mallik A, Zeng RS (2013) Control of Panama disease of banana by rotating and intercropping with Chinese chive (Allium tuberosum Rottler): role of plant volatiles. J Chem Ecol 39:243–252
142. Zhang J, Du Y, Wu C, Ren X, Ti X, Shi J et al (2010) Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186* signaling pathway. Oncol Rep 24:1217–1223
143. Zhang P, Wang Z, Chong T, Ji Z (2012a) Matrine inhibits proliferation and induces apoptosis of the androgenindependent prostate cancer cell line PC-3. Mol Med Rep 5:783–787
144. Zhang S, Zhang Y, Zhuang Y, Wang J, Ye J, Zhang S et al (2012b) Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation. PLoS One 7:e46853
145. Zubrod CG (1972) The national program for cancer chemotherapy. JAMA 222:1161–1162